Surgery Partners, Inc. (NASDAQ:SGRY) Receives $27.11 Average Target Price from Brokerages

Surgery Partners, Inc. (NASDAQ:SGRY) has been assigned an average rating of “Moderate Buy” from the ten analysts that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have given a buy rating to the company. The average 12 month price target among analysts that have covered the stock in the last year is $27.1111.

A number of research firms have weighed in on SGRY. Royal Bank Of Canada decreased their target price on shares of Surgery Partners from $35.00 to $31.00 and set an “outperform” rating for the company in a research report on Tuesday, November 11th. Barclays decreased their price objective on shares of Surgery Partners from $24.00 to $18.00 and set an “equal weight” rating for the company in a research report on Friday, November 21st. UBS Group cut their price target on shares of Surgery Partners from $34.00 to $29.00 and set a “buy” rating on the stock in a research report on Thursday, November 13th. Mizuho decreased their price target on Surgery Partners from $22.00 to $19.00 and set an “outperform” rating for the company in a report on Thursday, December 18th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Surgery Partners in a research note on Monday, December 29th.

Institutional Trading of Surgery Partners

Several large investors have recently modified their holdings of SGRY. Pentwater Capital Management LP lifted its position in shares of Surgery Partners by 66.9% during the 3rd quarter. Pentwater Capital Management LP now owns 11,681,000 shares of the company’s stock valued at $252,777,000 after acquiring an additional 4,681,000 shares during the period. UBS Group AG raised its holdings in shares of Surgery Partners by 111.4% during the fourth quarter. UBS Group AG now owns 7,803,974 shares of the company’s stock valued at $120,571,000 after purchasing an additional 4,113,052 shares during the period. Vanguard Group Inc. raised its holdings in shares of Surgery Partners by 5.9% during the third quarter. Vanguard Group Inc. now owns 7,614,514 shares of the company’s stock valued at $164,778,000 after purchasing an additional 424,518 shares during the period. King Street Capital Management L.P. boosted its position in shares of Surgery Partners by 24.5% during the 2nd quarter. King Street Capital Management L.P. now owns 6,225,000 shares of the company’s stock worth $138,382,000 after purchasing an additional 1,225,000 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its stake in shares of Surgery Partners by 1.0% in the 4th quarter. Dimensional Fund Advisors LP now owns 4,906,580 shares of the company’s stock valued at $75,808,000 after buying an additional 46,365 shares during the period.

Surgery Partners Price Performance

SGRY stock opened at $15.46 on Thursday. The company has a market capitalization of $2.00 billion, a P/E ratio of -11.37 and a beta of 1.97. The company has a fifty day moving average price of $15.45 and a 200-day moving average price of $18.90. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.72 and a current ratio of 1.88. Surgery Partners has a 52-week low of $13.14 and a 52-week high of $26.16.

Surgery Partners Company Profile

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.